Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies.
Myocarditis, often initiated by viral infection, may progress to autoimmune inflammatory heart disease, dilated cardiomyopathy and heart failure. Although cardiac myosin is a dominant autoantigen in animal models of myocarditis and is released from the heart during viral myocarditis, the characterization, role and significance of anti-cardiac myosin autoantibodies is poorly defined. In our study, we define the human cardiac myosin epitopes in human myocarditis and cardiomyopathies and establish a mechanism to explain how anti-cardiac myosin autoantibodies may contribute to heart disease. We show that autoantibodies to cardiac myosin in sera from myocarditis and dilated cardiomyopathies in humans targeted primarily epitopes in the S2 hinge region of cardiac myosin. In addition, anti-cardiac myosin antibodies in sera or purified IgG from myocarditis and cardiomyopathy targeted the beta-adrenergic receptor and induced antibody-mediated cAMP-dependent protein kinase A (PKA) cell signaling activity in heart cells. Antibody-mediated PKA activity in sera was abrogated by absorption with anti-human IgG. Antibody-mediated cell signaling of PKA was blocked by antigen-specific inhibition by human cardiac myosin or the beta-adrenergic receptor but not the alpha adrenergic receptor or bovine serum albumin. Propranolol, a beta blocker and inhibitor of the beta-adrenergic receptor pathway also blocked the antibody-mediated signaling of the beta-adrenergic receptor and PKA. The data suggest that IgG antibody against human cardiac myosin reacts with the beta-adrenergic receptor and triggers PKA signaling in heart cells. In summary, we have identified a new class of crossreactive autoantibodies against human cardiac myosin and the beta-adrenergic receptor in the heart. In addition, we have defined disease specific peptide epitopes in the human cardiac myosin rod S2 region in human myocarditis and cardiomyopathy as well as a mechanistic role of autoantibody in the pathogenesis of disease.
Mascaro-Blanco
Adita
A
Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Alvarez
Kathy
K
Yu
Xichun
X
Lindenfeld
JoAnn
J
Olansky
Leann
L
Lyons
Timothy
T
Duvall
David
D
Heuser
Janet S
JS
Gosmanova
Albina
A
Rubenstein
Carl J
CJ
Cooper
Leslie T
LT
Kem
David C
DC
Cunningham
Madeleine W
MW
D058672:Adrenergic beta-2 Receptor Antagonists; D000595:Amino Acid Sequence; D001323:Autoantibodies / Q000097:blood / Q000276:immunology*; D024722:Cardiac Myosins / Q000276:immunology*; D009202:Cardiomyopathies / Q000276:immunology* / Q000378:metabolism; D002311:Cardiomyopathy, Dilated / Q000276:immunology / Q000378:metabolism; D003429:Cross Reactions; D017868:Cyclic AMP-Dependent Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D000939:Epitopes; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D008969:Molecular Sequence Data; D009205:Myocarditis / Q000276:immunology* / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D018343:Receptors, Adrenergic, beta-2 / Q000378:metabolism
D058672:Adrenergic beta-2 Receptor Antagonists; D001323:Autoantibodies; D000939:Epitopes; D007074:Immunoglobulin G; D018343:Receptors, Adrenergic, beta-2; D011433:Propranolol; D017868:Cyclic AMP-Dependent Protein Kinases; D024722:Cardiac Myosins
Am J Cardiovasc Pathol. 1987 Jan;1(1):3-14
3455232
J Exp Med. 1995 Mar 1;181(3):1123-31
7869033
J Immunol. 1991 Oct 1;147(7):2141-7
1918949
Circulation. 1992 May;85(5):1734-42
1533350
Ernst Schering Res Found Workshop. 2006;(55):169-93
16329663
Heart. 1997 Jan;77(1):62-7
9038697
J Biol Chem. 1984 Sep 25;259(18):11226-30
6147352
Hum Pathol. 1987 Jun;18(6):619-24
3297992
Clin Immunol Immunopathol. 1993 Aug;68(2):118-23
7689424
Nat Med. 2003 Jul;9(7):914-20
12819778
J Immunol. 2006 Dec 1;177(11):8234-40
17114501
J Immunol. 1987 Dec 1;139(11):3630-6
3680946
J Exp Med. 2006 Aug 7;203(8):2009-19
16880257
J Clin Invest. 1993 Dec;92(6):2877-82
7504694
Nature. 1970 Aug 15;227(5259):680-5
5432063
Clin Immunol Immunopathol. 1990 Nov;57(2):250-62
2208806
Clin Exp Immunol. 1982 Jun;48(3):533-45
6288291
Eur J Heart Fail. 2002 Aug;4(4):411-7
12167378
J Immunol. 1997 Dec 1;159(11):5422-30
9548482
J Am Coll Cardiol. 2000 Jan;35(1):11-8
10636253
Nat Med. 1999 Mar;5(3):266-7
10086375
Semin Immunol. 1998 Feb;10(1):5-13
9529651
Nature. 2002 Jan 10;415(6868):206-12
11805844
Immunogenetics. 1999 Feb;49(2):79-85
9887344
Autoimmunity. 2001;34(3):211-5
11908780
Am J Pathol. 2002 Jan;160(1):297-306
11786423
J Immunol. 2005 Jan 1;174(1):261-9
15611248
Am J Cardiol. 1983 Nov 1;52(8):1072-8
6356861
J Clin Invest. 2004 May;113(10):1379-82
15146232
J Immunol. 1988 Oct 15;141(8):2760-6
3049816
J Am Coll Cardiol. 1990 Nov;16(6):839-46
2229805
J Exp Med. 1986 Oct 1;164(4):998-1012
3531385
Arch Pathol Lab Med. 1989 Dec;113(12):1357-62
2480099
Am J Pathol. 1980 Mar;98(3):681-94
6244737
N Engl J Med. 1997 Jun 26;336(26):1860-6
9197214
N Engl J Med. 2003 Oct 16;349(16):1526-33
14561795
Autoimmunity. 2001;34(3):199-204
11908778
Am J Med. 1995 Sep;99(3):309-14
7653492
Herz. 2000 May;25(3):291-8
10904855
Am J Pathol. 2004 Dec;165(6):1883-94
15579433
J Immunol. 2004 Mar 1;172(5):3225-34
14978130
Eur Heart J. 1997 Feb;18(2):270-5
9043844
J Immunol. 1999 Jul 15;163(2):1060-5
10395705
Am Heart J. 1993 Dec;126(6):1385-92
7504393
Circ Res. 1994 Aug;75(2):278-84
8033341
Clin Microbiol Rev. 2000 Jul;13(3):470-511
10885988
Medicine (Baltimore). 1999 Jul;78(4):270-83
10424207
Circ Res. 1995 Jan;76(1):64-72
8001279
Am J Physiol. 1988 Oct;255(4 Pt 2):H960-4
2845818
J Immunol. 1992 Jun 15;148(12):3806-13
1602130
J Clin Invest. 2004 May;113(10):1419-29
15146239
Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1320-4
1311095
Genomics. 1990 Oct;8(2):194-206
2249844
J Immunol. 1989 Oct 15;143(8):2677-83
2677144
Int J Cardiol. 1996 May;54(2):157-63
8803680
Circ Res. 2000 Feb 18;86(3):281-5
10679479
Am J Pathol. 1980 Nov;101(2):425-84
6254364
Ernst Schering Res Found Workshop. 2006;(55):141-54
16331858
J Clin Invest. 2000 Jul;106(2):217-24
10903337